Leading Global ME/CFS Research by Putting Patients at the Center
At the Solve ME/CFS Initiative, we have a deep and longstanding commitment to this disease. We were the first to fund research into epidemiology, viral causes, immunology, neuroimaging, exercise physiology and the autonomic nervous system.
Our SolveCFS BioBank provides the means for patients to participate in research without leaving their homes, broadening the base of patients studied.
There is a big gap in the ME/CFS research pipeline that moves basic laboratory research and discoveries into safe and effective treatments. Think of it like railroad tracks that stop at the edge of a canyon. Without a bridge to bring these remarkable discoveries to the clinic, laboratory research rarely becomes more than a science paper.
Under the RIWW, we have a number of programs that engage patients, caregivers, researchers and physicians in the research process, including:
The SolveCFS BioBank is a popular way for ME/CFS patients to actively participate in research from anywhere in the world.
Innovative Drug Repurposing
We are funding research to identify new applications for existing, approved therapies. Working with pharma and biotech companies, we are identifying drugs that we already know work in one way that we think may have application for ME/CFS.
Strategic Research Investment
Since 1987, SMCI has been the largest private funder of ME/CFS research. We have directly funded or leveraged more than $12 million in ME/CFS research studies in the past five years alone, all aimed at accelerating progress toward accurate diagnosis and effective treatment of ME/CFS.
Read our 2013 Year-End Summary: Advancing Science: A Case for Hope, a Look Ahead